Opioid Tolerance After Detox: Why Overdose Risk Can Increase
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
One of the most important risks after opioid detox is easy to misunderstand: a person may remember how much opioid they used before treatment, but their body may no longer tolerate that amount in the same way after a period of abstinence.
Repeated opioid use can produce tolerance, meaning the body becomes less responsive to a particular amount of opioid. When regular opioid exposure stops, tolerance can decrease. If opioid use later returns, an amount that was previously tolerated may produce much stronger effects, including dangerous respiratory depression and overdose.
This is one reason opioid relapse after detox can become medically dangerous. Reduced tolerance can combine with unpredictable illicit drug potency, fentanyl exposure, alcohol or sedative use, and delays in emergency treatment.
Related: Because overdose risk can rise after tolerance falls, it is important to plan what comes next. Read about moving from active opioid use toward naltrexone treatment.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an evidence-informed educational resource and is awaiting formal clinical approval. Until formal review has been completed, it should not be represented as medically reviewed.
View Dr Fergus Law’s professional profile
The Body Can Change Faster Than the Memory of the Previous Dose
Before detox, someone may have developed substantial opioid tolerance through repeated use. They may remember particular amounts as familiar or normal.
After opioids are stopped, that previous tolerance does not necessarily remain at the same level.
This creates a dangerous mismatch.
The person may remember a previous dose as something their body could handle while their current physiology has changed.
A previously tolerated opioid amount cannot be assumed to remain tolerated after detox or another period of abstinence.
In This Guide
- What opioid tolerance means
- Tolerance versus dependence
- What happens after detox
- Why returning to a previous amount is dangerous
- Fentanyl and unpredictable potency
- Alcohol, benzodiazepines and sedatives
- When risk may be particularly high
- Naloxone and overdose response
- Treatment after detox
- Naltrexone and opioid sensitivity
- What families should know
- Frequently asked questions
- Clinical sources
What Is Opioid Tolerance?
Opioid tolerance describes a reduced response to an opioid after repeated exposure.
Over time, a person may require a greater amount of an opioid to produce effects similar to those previously produced by a smaller amount.
CDC defines opioid tolerance as a situation in which a person experiences a reduced response and may require more opioid to produce the same effect.
The Body Adapts
Repeated opioid exposure can change the body’s response to the drug.
The Same Amount Has Less Effect
A dose that once produced strong effects may produce less effect after repeated exposure.
Previous Tolerance May Decline
When opioid exposure stops or decreases substantially, the previous level of tolerance may no longer remain.
Even people with substantial opioid tolerance can overdose, particularly when drug strength is unpredictable, fentanyl is involved, multiple substances are combined or respiratory depression becomes severe.
Opioid Tolerance, Physical Dependence and Opioid Use Disorder Are Not the Same Thing
These terms describe different concepts.
| Term | What It Means |
|---|---|
| Tolerance | A reduced response to an opioid after repeated exposure, so more may be needed to produce a similar effect. |
| Physical Dependence | Physiological adaptation in which stopping or reducing opioids can produce withdrawal symptoms. |
| Opioid Use Disorder | A clinical disorder involving a pattern of problematic opioid use associated with significant impairment or distress. |
A person can develop tolerance or physical dependence while taking an opioid under appropriate medical supervision without automatically meeting criteria for opioid use disorder.
Conversely, someone with opioid use disorder may have important relapse and overdose risks even after acute physical dependence has been addressed.
What Happens to Opioid Tolerance After Detox?
During detoxification or medically supervised withdrawal, regular opioid exposure is reduced and ultimately stopped.
As abstinence continues, tolerance can decline.
The exact degree and timing of that change varies between individuals. It depends on factors including previous opioid exposure, the substances involved, duration of use, treatment medications and individual physiology.
Repeated Opioid Use
Tolerance may develop over time.
Detox Begins
Regular opioid exposure decreases or stops.
Abstinence Continues
Previous tolerance may decrease.
Opioid Use Returns
The person may remember the previous amount rather than their changed tolerance.
Overdose Risk
Respiratory depression can become stronger and life-threatening.
This is one reason detox alone may not be enough for opioid recovery .
Why Can Returning to the Same Opioid Amount Be Dangerous?
A person may remember an amount of heroin, fentanyl, oxycodone or another opioid that they previously used without experiencing an obvious overdose.
After abstinence, that memory can become dangerously misleading.
CDC identifies returning to a high opioid dose after losing tolerance as an important overdose risk factor.
There is also no reliable way to calculate a “safe” dose of an illicit opioid after abstinence.
Illicit drug composition can vary, and fentanyl or other potent substances may be present without the person knowing.
Illicit Fentanyl Makes Previous Dose Experience Even Less Reliable
Reduced tolerance is not the only reason a return to opioid use can be dangerous.
The illicit drug supply can be unpredictable.
A person may believe they are using heroin or a prescription-type tablet while the substance contains illegally manufactured fentanyl or another potent opioid.
Potency Can Vary
Two products sold as the same drug may contain very different amounts or combinations of active substances.
Fake Pills Can Contain Fentanyl
Counterfeit tablets may resemble legitimate prescription medications while containing illicit fentanyl.
Tolerance May Be Lower
After detox, the body’s previous adaptation to opioids may have decreased.
The Combination Can Be Dangerous
Lower tolerance plus unexpectedly potent opioid exposure can substantially increase overdose danger.
Alcohol, Benzodiazepines and Other Sedating Drugs Can Increase Danger
Opioids can slow breathing.
Combining them with other substances that depress the central nervous system can further increase overdose risk.
Important examples include:
- alcohol;
- benzodiazepines;
- other opioids;
- some sleep medications;
- other sedating medicines or substances.
CDC specifically warns that combining opioids with substances such as alcohol and benzodiazepines can increase overdose risk.
When Can Overdose Risk Be Particularly Important After Detox?
There is no universal day on which overdose risk suddenly peaks for every person.
However, the period soon after detox or treatment discharge deserves particular attention because several risk factors may appear at the same time.
Lower Tolerance
The person may no longer tolerate the opioid amounts they remember using before treatment.
Return to Familiar Triggers
Leaving treatment can reintroduce people, places and routines associated with opioid use.
Cravings
Cravings can continue after withdrawal and may intensify when familiar triggers reappear.
Treatment Gaps
A delay between detox and continuing treatment can leave important OUD symptoms insufficiently addressed.
Easy Access
Returning home may reconnect someone with previous opioid supply routes.
Unpredictable Drug Supply
Fentanyl and counterfeit pills can make the strength of illicit drugs difficult or impossible to predict.
Read the dedicated guide: When Is Opioid Relapse Risk Highest After Detox? .
Naloxone Should Be Part of the Post-Detox Safety Plan
Naloxone is an opioid antagonist that can temporarily reverse an opioid overdose.
Where future opioid exposure is possible, access to naloxone and knowledge of how to use it can be lifesaving.
Family members, partners and other people close to someone with opioid use disorder can also learn to recognise an overdose and administer naloxone.
If someone cannot be awakened, has very slow, irregular or stopped breathing, or opioid overdose is suspected, administer naloxone if available and contact emergency services immediately.
SAMHSA recommends immediate emergency action for suspected opioid overdose and advises that naloxone or another approved opioid overdose reversal medication be used when available.
Possible Signs of Opioid Overdose
Family members and people in recovery should know that opioid overdose can involve:
Unable to Wake
The person does not respond normally to voice or touch.
Abnormal Breathing
Breathing may become very slow, shallow, irregular or stop completely.
Blue or Discoloured Lips
Lips, fingertips or skin may become blue, purple, pale or otherwise discoloured.
Gurgling or Choking Sounds
Unusual snoring, choking or gurgling sounds can occur when breathing is severely impaired.
Continuing OUD Treatment Can Reduce the Risks That Follow Detox
CDC advises that detoxification alone without medications for opioid use disorder is not recommended because of increased risks of resuming opioid use, overdose and overdose death.
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
Buprenorphine
Can reduce withdrawal symptoms and cravings and be continued as treatment for opioid use disorder.
Methadone
Can reduce opioid withdrawal and cravings and may be used as continuing treatment for OUD.
Naltrexone
Blocks opioid receptors and requires appropriate opioid-free preparation before initiation.
Medication choice depends on factors including current opioid exposure, previous treatment, clinical history, patient preference, treatment availability and other medical considerations.
Naltrexone, Reduced Tolerance and Overdose Risk
Naltrexone is an opioid receptor antagonist that blocks opioid effects while sufficient medication levels are present.
SAMHSA warns that people treated with naltrexone can become more sensitive to opioids after reduced opioid exposure.
As the blocking effect decreases or ends, opioid amounts previously used may produce stronger effects than expected because tolerance has been reduced.
Trying to overcome opioid blockade by taking large quantities of opioids can cause serious injury, coma or death. Overdose vulnerability may also increase when antagonist protection declines or ends.
Naltrexone should also not be initiated while significant opioid physical dependence remains because it can precipitate withdrawal.
Long-Acting Naltrexone
Longer-acting formulations may reduce reliance on daily medication-taking decisions and can form part of relapse-prevention planning for appropriately selected patients.
Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States. DeBinge treatment involving long-acting implant-based naltrexone takes place in Nassau, The Bahamas, following individual clinical assessment.
Learn more: Long-Acting Naltrexone Implant .
Families Should Know That Previous Tolerance Can Be Misleading
Family members may understandably believe that because someone previously used large amounts of opioids, their body can still tolerate those amounts.
After detox or another period of abstinence, that assumption can be dangerous.
Keep naloxone accessible
Know where it is stored and how to administer it.
Know overdose warning signs
Unresponsiveness and abnormal breathing require immediate action.
Understand reduced tolerance
Do not assume previous opioid exposure protects someone after abstinence.
Support continuing treatment
Help reduce practical barriers to medication, counselling and follow-up when the person wants that support.
Respond early to relapse warning signs
Strong cravings, missed treatment and renewed contact with previous opioid networks deserve attention before a medical emergency occurs.
Do Not Assume Previous Experience Makes the Situation Safe
Someone may have used opioids for years before treatment and still be vulnerable to overdose after abstinence.
Previous opioid experience does not reliably tell someone how their body will respond now.
It also cannot tell them the true potency or contents of an illicit drug.
Administer naloxone if available, contact emergency services immediately and remain with the person until professional help arrives.
Once immediate safety has been addressed, reconnect with treatment promptly and review what contributed to the return to opioid use.
Reduced Tolerance Is One Reason Relapse Prevention Matters After Detox
Overdose prevention should not begin only after opioid use has already returned. Continuing treatment, medication, craving management, trigger planning, naloxone, counselling and rapid response to warning signs can all form part of the wider strategy.
Plan Beyond Detox
DeBinge provides addiction treatment in Nassau, The Bahamas. For suitable patients, assessment may include discussion of long-acting naltrexone alongside counselling and continuing relapse-prevention planning.
Individual suitability depends on factors including current opioid exposure, completion of an appropriate opioid-free period, previous treatment, medication history, physical and mental health, and recovery goals.
Opioid Tolerance After Detox: FAQs
Does opioid tolerance decrease after detox?
Yes. When regular opioid exposure stops or decreases substantially, previous opioid tolerance can decline. The extent and timing vary between individuals.
Why does lower opioid tolerance increase overdose risk?
After tolerance decreases, an amount of opioid previously tolerated may produce stronger effects, including severe respiratory depression and overdose.
Can someone overdose using the same amount they used before detox?
Yes. A previously tolerated amount may become dangerous after a period of abstinence because tolerance can decrease. Drug potency and composition may also have changed.
How quickly does opioid tolerance decrease?
There is no single timeline that applies to everyone. Tolerance can change after opioid use is reduced or stopped, and individual physiology, previous exposure and treatment circumstances differ. A previous dose should not be assumed to remain tolerated after abstinence.
Why is fentanyl especially dangerous after detox?
Reduced tolerance can increase vulnerability while illicitly manufactured fentanyl can make drug potency difficult to predict. A person may also unknowingly encounter fentanyl in heroin or counterfeit pills.
Does mixing opioids with alcohol increase overdose risk?
Yes. Alcohol and other central nervous system depressants can increase the respiratory-depressant effects associated with opioids.
Do benzodiazepines increase opioid overdose risk?
Combining opioids with benzodiazepines can increase overdose risk because both can contribute to sedation and respiratory depression.
Should someone have naloxone after opioid detox?
Where opioid exposure remains possible, naloxone and overdose-response education should form part of the post-detox safety plan.
Does naltrexone prevent all opioid overdoses?
No. Attempting to overcome opioid blockade with large opioid quantities can be dangerous, and overdose vulnerability can increase when naltrexone’s blocking effects decline because opioid tolerance may be lower.
Is detox enough to treat opioid use disorder?
CDC does not recommend detoxification alone without medication treatment for opioid use disorder because of increased risks of returning to opioid use, overdose and overdose death.
What should happen if someone uses opioids after detox?
Address overdose safety immediately. If overdose is suspected, administer naloxone if available and contact emergency services. After immediate safety is addressed, reconnect with treatment promptly.
Are naltrexone implants FDA-approved in the United States?
No. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.
Evidence Used in This Guide
CDC — About Prescription Opioids
CDC information on opioid overdose risk factors, including returning to a high dose after loss of opioid tolerance.
CDC — Risks and How to Reduce Them
CDC guidance covering overdose risk factors, naloxone and what to do when opioid overdose is suspected.
CDC — Opioid Use Disorder: Treating
CDC guidance explaining why detoxification alone is not recommended as complete OUD treatment and describing evidence-based medications for opioid use disorder.
SAMHSA — Opioid Overdose Prevention and Reversal
Current SAMHSA guidance covering opioid overdose recognition, prevention, naloxone and increased sensitivity to opioids after reduced tolerance.
SAMHSA — Opioid Overdose Reversal Medications
SAMHSA information about naloxone, nalmefene, opioid overdose signs and emergency response.
SAMHSA — Naltrexone
Current SAMHSA information on naltrexone, opioid blockade and overdose vulnerability associated with increased opioid sensitivity.
SAMHSA — TIP 63: Medications for Opioid Use Disorder
SAMHSA’s treatment guidance covering methadone, buprenorphine and naltrexone and other strategies supporting recovery from opioid use disorder.
SAMHSA — Prescription Opioids and Fake Pills
SAMHSA information covering prescription opioid risks and counterfeit pills that may contain illicit fentanyl.
Individual opioid tolerance cannot be calculated reliably from an online article. Drug potency, illicit drug composition and individual physiology can vary substantially. Clinical recommendations and regulatory information can also change.
Related: Because overdose risk can rise after tolerance falls, it is important to plan what comes next. Read about moving from active opioid use toward naltrexone treatment.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an educational resource concerning opioid tolerance, post-detox overdose risk, naloxone and continuing treatment for opioid use disorder. It is awaiting formal clinical approval.
View Dr Fergus Law’s professional profile
This Article Does Not Establish a Safe Opioid Dose
This page provides general educational information. It cannot determine an individual’s opioid tolerance and should never be used to calculate a supposedly safe opioid dose after detox, rehab, incarceration, naltrexone treatment or another period of abstinence.
Illicit opioid potency and composition can be unpredictable, including possible exposure to illegally manufactured fentanyl.
Do not abruptly stop methadone, buprenorphine, prescribed opioids or another prescribed medication based on this article.
Naltrexone requires appropriate opioid-free preparation before initiation. Starting naltrexone while significant opioid physical dependence remains can precipitate withdrawal.
If someone cannot be awakened, has very slow or stopped breathing, or opioid overdose is suspected, administer naloxone if available and contact local emergency services immediately.
DeBinge is located in Nassau, The Bahamas. We do not operate a treatment facility in the United States. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.